|
April 18, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:08 FDA approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) as first-line treatment for patients with intermediate- and poor-risk advanced renal cell carcinoma https://news.bms.com/press-release/corporatefinancial-news/us-food-and-drug-administration-approves-opdivo-nivolumab-yerv 3:22 CRISPR Therapeutics plans to treat first patients for Beta Thalassemia in Europe https://www.biospace.com/article/crispr-therapeutics-plans-to-treat-first-patients-for-beta-thalassemia-in-europe/ 6:17 Variant Pharmaceuticals Completes Pre-IND Meeting with FDA on VAR 200 for Focal Segmental Glomerulosclerosis (FSGS), a Rare Kidney Disease https://www.prnewswire.com/news-releases/variant-pharmaceuticals-completes-pre-ind-meeting-with-fda-on-var-200-for-focal-segmental-glomerulosclerosis-fsgs-a-rare-kidney-disease-300629892.html Udemy course Freelance Medical Writing as a Career Choice. This is a 35-minute course giving an overview of what qualifications are needed, what skills and attributes are helpful and how much money you can make. https://www.udemy.com/freelance-medical-writing-career/?couponCode=MEDICALWRITING Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/ |
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation